SLCO2B1 and SLCO1B3 May Determine Time to Progression for Patients Receiving Androgen Deprivation Therapy for Prostate Cancer

PURPOSE: Androgen deprivation therapy (ADT), an important treatment for advanced prostate cancer, is highly variable in its effectiveness. We hypothesized that genetic variants of androgen transporter genes, SLCO2B1 and SLCO1B3, may determine time to progression on ADT. PATIENTS AND METHODS: A cohor...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Yang, Ming, Xie, Wanling, Mostaghel, Elahe, Nakabayashi, Mari, Werner, Lillian, Sun, Tong, Pomerantz, Mark, Freedman, Matthew, Ross, Robert, Regan, Meredith, Sharifi, Nima, Figg, William Douglas, Balk, Steven, Brown, Myles, Taplin, Mary-Ellen, Oh, William K., Lee, Gwo-Shu Mary, Kantoff, Philip W.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2011
Assuntos:
Original Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3138634/
https://ncbi.nlm.nih.gov/pubmed/21606417
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2010.31.2405
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados